Clinical Outcomes of Severe Lassa Fever in West Africa: A Systematic Review and Meta-Analysis
International Journal of Environmental Research and Public Health · 30.09.2025 · 22 (10) · 1504
DOI: 10.3390/ijerph22101504 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 30.09.2025. Verfasst von Azuka Patrick Okwuraiwe und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Lagos 101212, Nigeria. Hauptthemen laut MEDLINE: Lassa Fever. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nigerian Institute of Medical Research Foundation, Nigerian Institute for Medical Research Foundation.
Abstract (Originalsprache)
Lassa fever (LF) is an acute viral hemorrhagic fever that poses a substantial public health security threat in West Africa. The non-specific clinical presentation of LF, coupled with a lack of reliable point-of-care diagnostics, means delayed diagnosis, leading to severe complications and mortality during epidemics. A systematic review and meta-analyses were performed by conducting an extensive online search using PubMed, Web of Science, Scopus, CINAHL, and Google Scholar (PROSPERO protocol identifier number CRD42024587426). Only peer-reviewed studies written in English were included in publications from 1 September 2014, to 31 August 2024. The analysis and reporting followed PRISMA guidelines. The quality of the included studies was assessed using the critical appraisal tools developed from the Joanna Briggs Institute Systematic Review Checklist for cohort studies. We included 19 studies that contained data from 4177 patients hospitalized with LF of any age. Most included studies employed a retrospective cohort design and were conducted in Nigeria (16/19; 84.2%). The mortality rate was highest in a Sierra Leonean study (63.0%), whereas a group-based analysis of Nigerian studies using a random-effects model identified Owo as having the highest mortality rate of 13% (95% CI: 6–23; I2 = 98%). The pooled mortality rate for severe LF was 19% (95% confidence interval [CI]:10–32). The most common complications of LF are acute kidney injury (AKI) at a pooled proportion of 19% (95% CI; 13–26; I2 = 89%)), followed by abnormal bleeding at a pooled proportion of 17% (95% CI; 9–30; I2 = 98%), and central nervous system (CNS) dysfunction at a pooled proportion of 15% (95% CI; 6–32; I2 = 98%). With one out of every five hospitalized LF patients likely to die in West Africa, accelerating the development of rapid diagnostic tests, licensed vaccines, and novel therapeutics is crucial. Strengthening community engagement and risk communication, developing regional treatment guidelines, decentralizing LF care units, and training healthcare workers using a harmonized curriculum will enhance early diagnosis and effective case management, thereby reducing severe complications and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Lagos 101212, Nigeria.
- Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt 500001, Nigeria.
- Department of Microbiology, Veritas University, Bwari Area Council, Abuja 900106, Nigeria.
- Department of Human Anatomy, Federal University, Dutse 720101, Nigeria.
- Department of Clinical Pharmacy and Pharmacy Practice, Ahmadu Bello University, Zaria 800001, Nigeria.
- Department of Community Health and Primary Care, Lagos University Teaching Hospital, Lagos 100254, Nigeria.
ORCID-Profile: Azuka Patrick Okwuraiwe, Chizaram Anselm Onyeaghala, Muritala Odidi Suleiman, Samirah Nndwan Abdu-Aguye, Nkolika Jacinta Ezekwelu, Tolulope Amos Oyeniyi, Ayodapo Oluwadare Jegede, Olunike Rebecca Abodunrin, Olajide Odunayo Sobande
Förderung
- Nigerian Institute of Medical Research Foundation
- Nigerian Institute for Medical Research Foundation
Zitieren
APA
Okwuraiwe, A. P., Onyeaghala, C. A., Ozoude, O. T., Suleiman, M. O., Abdu-Aguye, S. N., Ezekwelu, N. J., Oyeniyi, T. A., Jegede, A. O., Egwudo, A. E., Okeke, O. P., Abodunrin, O. R., Akinsolu, F. T., & Sobande, O. O. (2025). Clinical Outcomes of Severe Lassa Fever in West Africa: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health, 22(10), 1504. https://doi.org/10.3390/ijerph22101504
Vancouver
Okwuraiwe AP, Onyeaghala CA, Ozoude OT, Suleiman MO, Abdu-Aguye SN, Ezekwelu NJ, et al. Clinical Outcomes of Severe Lassa Fever in West Africa: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2025;22(10):1504. doi:10.3390/ijerph22101504
BibTeX
@article{Okwuraiwe2025,
author = {Okwuraiwe, Azuka Patrick and Onyeaghala, Chizaram Anselm and Ozoude, Obiageli Theresa and Suleiman, Muritala Odidi and Abdu-Aguye, Samirah Nndwan and Ezekwelu, Nkolika Jacinta and Oyeniyi, Tolulope Amos and Jegede, Ayodapo Oluwadare and Egwudo, Adaeze Elfrida and Okeke, Oluchukwu Perpetual and Abodunrin, Olunike Rebecca and Akinsolu, Folahanmi Tomiwa and Sobande, Olajide Odunayo},
title = {Clinical Outcomes of Severe Lassa Fever in West Africa: A Systematic Review and Meta-Analysis},
journal = {International Journal of Environmental Research and Public Health},
year = {2025},
volume = {22},
number = {10},
pages = {1504},
doi = {10.3390/ijerph22101504}
}
EUVIMED